Innovation
ASH 23 Posters
GTC presented abstracts at ASH 2023 GTC’s posters from 2023 Convention of American Society of Hematology are now available to be downloaded. Please reach out
December 12, 2023 10:31 am
genomic testing
Read More »
Article
Τumor-informed vs Tumor-naïve
Liquid biopsies are a rapidly evolving diagnostic technology with numerous labs offering commercially available tests today. Most labs have taken an approach of cell-free (cfDNA)
July 3, 2023 10:36 am
Innovation
ASCO 23 Posters
GTC presented abstracts at ASCO 2023 GTC’s posters from 2023 Convention of American Society of Clinical Oncology are now available to be downloaded. Please reach
June 8, 2023 11:12 am
Article
New publication on how cfRNA and AI are advancing LBx
GTC has a new publication in Heliyon titled “The Potential of Cell-Free RNA in Liquid Biopsy: Comprehensive Analysis of Mutation Profile, Chromosomal Abnormalities, and Immune
May 23, 2023 11:37 am
Innovation
In Move to Power Precision Oncology for Patients, COTA and Genomic Testing Cooperative Form New Data Partnership
Combining Longitudinal Real-World Data and Clinical Genomics Data Will Enable a More Precise Approach to Cancer Care and Research NEW YORK – COTA, Inc., an
March 8, 2023 5:05 am
Publications
New paper in Journal of Medical Artificial Intelligence
GTC was recently published in the Journal of Medical Artificial Intelligence – Accuracy of predicting IgHV mutation status in chronic lymphocytic leukemia using RNA expression profiling and machine learning.
November 8, 2022 10:44 am
Article
Meet Us at ASH – Happy hour event
ASH is just over a month away. Come meet with the GTC team and its co-op partners at our happy hour event. Download your invitation
November 4, 2022 9:34 am
Innovation
Genomic Testing Cooperative Implementing AI, Molecular Profiling to Improve Cancer Diagnosis
CHICAGO – With the publication of a paper validating two artificial intelligence-based algorithms for assisting pathologists in molecular profiling of patients, the Genomic Testing Cooperative
November 3, 2022 9:02 am
Article
What are some of the hematologic manifestations of VEXAS syndrome?
A Man with a Recurrent Left Pleural Effusion In late 2020, a new disease entity that was referred to as VEXAS (vacuoles, E1 enzyme, X-linked,
March 16, 2022 12:28 pm
Innovation
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
Abstract Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology; however, these biological subgroups overlap
February 1, 2022 9:54 am